Regenerative Medicine Spin Off Technology Moves Closer To Clinical Use
A commercial version of technologies developed in the McGowan Medical Devices Prototype Laboratory (MMDPL) at the McGowan Institute for Regenerative Medicine has moved one step closer to serving the needs of patients with respiratory distress. ALung Technologies, Inc., a University of Pittsburgh licensee, presented an analysis of its recent clinical trial of the Hemolung Respiratory Assist System (RAS) (pictured) in patients with acute exacerbation of chronic obstructive pulmonary disease (COPD). The results of a clinical study in Germany were summarized in a paper that was presented at the 58th Annual Conference of the American Society of Artificial Internal Organs in San Francisco.